相关实验视频
Updated: May 9, 2026

09:30
Modeling Ligands into Maps Derived from Electron Cryomicroscopy
Published on: July 19, 2024
二酶2的X射线晶体结构与高度选择性的纳米分子抑制剂相结合,揭示了对选择性的重要结合诱导口袋
Jian Zhu1, Qiqi Yang, Dandan Dai
1State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, China.
Journal of the American Chemical Society
|August 1, 2013
概括
研究人员阐明了与选择性抑制剂复合的二酶2 (PDE2) 的结构. 这揭示了一个新的结合诱导的口袋,增强抑制剂选择性用于PDE2药物开发.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 药用化学 医学化学
背景情况:
- 人类固酶 (PDE) 酶在细胞信号传递中起着至关重要的作用.
- 了解PDE家族 (PDEs 1-11) 的抑制剂选择性对于有针对性的药物开发至关重要.
- 选择性PDE2抑制剂具有治疗意义.
研究的目的:
- 为了确定与选择性抑制剂复合的PDE2的X射线晶体结构.
- 阐明抑制剂对PDE2.2的选择性的结构基础.
- 为 PDE 抑制剂的基于结构的药物设计策略提供信息.
主要方法:
- 对PDE2抑制剂复合物和Apo PDE2的X射线晶体学.
- 在活性部位内分析蛋白质 - 配体相互作用.
- 在基分子对接和亲和概况.
主要成果:
- 报道了PDE2-BAY60-7550复合体 (1.9 Å) 和Apo PDE2 (2.0 Å) 的X射线晶体结构.
- 通过保存的谷氨胺开关和一种新的,结合诱导的疏水口袋,确定了抑制剂的结合.
- 分子对接证实,疏水口袋对结合亲和力和PDE2选择性有显著的贡献.
结论:
- 这项研究揭示了PDE2活性部位中以前未报告的结合诱导的口袋.
- 利用这种口袋是提高PDE药物发现中抑制剂选择性的可行策略.
- 为设计下一代高度选择性的PDE2抑制剂提供了结构基础.
相关概念视频
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

